Pre-Conference Workshop Discussions Day

Workshop A - 09:00 - 12:00

Driving Industry Collaboration to Validate a Digital Indicator of Efficacy & Disease Progression

Remote monitoring technologies present a pivotal opportunity to revolutionize clinical trial design within neuroscience. However, it is clear that global collaborative efforts will be critical to validating digital biomarkers to efficiency share costs, avoid duplication of data, and accelerate towards regulatory approval. Impeded by a plethora of digital biomarkers, what is needed to unite the industry to validate a remote marker of disease state? Join this workshop to explore opportunities for cross-industry collaboration and identify promising avenues for validation.

Highlights include:

  • Discussing the most promising tools to estimate relevant outcome measures and assessing a likely pathway to regulatory approval
  • Uniting stakeholders to collaboratively drive progress to validation of a digital biomarker

Workshop B - 1:00 - 4:00

Delineating Opportunities to Develop Digital Therapeutics
to Treat Neurological Conditions

With digital interventions using virtual reality, smartphones, and games creating interactive exercises for improving cognition, and increased digital delivery of treatment, digital therapeutics could transform approaches to decentralized treatment of neurological conditions. However, with more evidence needed to support clinical efficacy and challenges in regulation, what are the opportunities to employ digital therapeutics for motor, cognitive, and emotional recovery in combination with other therapies?

Highlights include:

  • Developing digital neurotherapeutics to promote recovery of motor skills, cognitive function, and emotion regulation
  • Paving the way to clinical validation: what is needed to validate efficacy of digital therapeutics?
  • Parkinson’s, Alzheimer’s, Depression, Anxiety and beyond: pioneering digital neurotherapeutics in a range of neurological conditions